SCOPUS 정보 검색 플랫폼

Volumn 43, Issue 7, 2001, Pages 595-599

Effect of probucol on the concentration of cyclosporin a in patients with nephrotic syndrome

(8) Wakasugi, Hiroko a Yoshimoto, Mari a Aoki, Maki a Osawa, Riyo a Futami, Takahiro a Ono, Takahiko b Muso, Eri b Inui, Ken Ichi a

a KYOTO UNIVERSITY HOSPITAL (Japan)

b KYOTO UNIVERSITY (Japan)

Author keywords

Cyclosporin A; Drug interaction; Hyperlipidemia; Nephrotic syndrome; Probucol

Indexed keywords

CYCLOSPORIN A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; PROBUCOL; STEROID;

ARTICLE; CHOLESTEROL BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG SAFETY; HUMAN; HYPERLIPIDEMIA; NEPHROTIC SYNDROME; RECURRENT DISEASE; SIDE EFFECT;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CYCLOSPORINE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERLIPIDEMIAS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEPHROTIC SYNDROME; PROBUCOL;

EID: 0034753743 PISSN: 03852385 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (3)

References (11)

1
- 0002808167
- Japanese source

2
- 0002698390
- Japanese source

3
- 0033043637
- For the Kansai-FGS-Apheresis Treatment Study Group. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome
- Muso E, Mune M, Fujii Y, Imai E, Ueda N, Hatta K, Imada A, Miki S, Kuwahara T, Takamitsu Y, Takemura T, Tsubakihara Y, For the Kansai-FGS-Apheresis Treatment Study Group. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome Kidney Int 1999 ; 56 : S122-5.
- (1999) Kidney Int , vol.56
- Muso, E.¹ Mune, M.² Fujii, Y.³ Imai, E.⁴ Ueda, N.⁵ Hatta, K.⁶ Imada, A.⁷ Miki, S.⁸ Kuwahara, T.⁹ Takamitsu, Y.¹⁰ Takemura, T.¹¹ Tsubakihara, Y.¹²

4
- 0002840419
- Japanese source

5
- 0002758443
- Japanese source

6
- 0027930820
- Interaction between probucol and cyclosporine in renal transplant patients
- Gallego C, Sanchez P, Planells C, Sanchez S, Monte E, Roma E, Sanchez J, Pallardo LM. Interaction between probucol and cyclosporine in renal transplant patients. Ann Pharmacother 1994 ; 28 : 940-3.
- (1994) Ann Pharmacother , vol.28 , pp. 940-943
- Gallego, C.¹ Sanchez, P.² Planells, C.³ Sanchez, S.⁴ Monte, E.⁵ Roma, E.⁶ Sanchez, J.⁷ Pallardo, L.M.⁸

7
- 0025899463
- Interaction of cyclosporine and probucol in heart transplant patients
- Sundararajan V, Cooper DKC, Muchmore J, Manton CV, Liguori C, Zuhdi N, Novitzky D, Chen PN, Bourne DWA, Corder CN. Interaction of cyclosporine and probucol in heart transplant patients. Transplant Proc 1991 ; 23 : 2028-32.
- (1991) Transplant Proc , vol.23 , pp. 2028-2032
- Sundararajan, V.¹ Cooper, D.K.C.² Muchmore, J.³ Manton, C.V.⁴ Liguori, C.⁵ Zuhdi, N.⁶ Novitzky, D.⁷ Chen, P.N.⁸ Bourne, D.W.A.⁹ Corder, C.N.¹⁰

8
- 0002846276
- Japanese source

9
- 1842338658
- For the Multivitamins and Probucol Study Group. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty
- Tardif JC, Coté G, Lespérance J, Bourassa M, Lambert J, Doucet S, Bilodeau L, Nattel S, Guise P, For the Multivitamins and Probucol Study Group. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997 ; 337 : 365-72.
- (1997) N Engl J Med , vol.337 , pp. 365-372
- Tardif, J.C.¹ Coté, G.² Lespérance, J.³ Bourassa, M.⁴ Lambert, J.⁵ Doucet, S.⁶ Bilodeau, L.⁷ Nattel, S.⁸ Guise, P.⁹

10
- 0030572991
- Decrease in oral bioavailability of cyclosporin a by coadministration of probucol in rats
- Sugimoto K, Sakamoto K, Fujimura A. Decrease in oral bioavailability of cyclosporin A by coadministration of probucol in rats. Life Sci 1997 ; 60 : 173-9.
- (1997) Life Sci , vol.60 , pp. 173-179
- Sugimoto, K.¹ Sakamoto, K.² Fujimura, A.³

11
- 0002702995
- Japanese source

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.